APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flunixin Meglumine Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Flunixin Meglumine Injection Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchFlunixin Meglumine Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Flunixin Meglumine Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Flunixin Meglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flunixin Meglumine Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Flunixin Meglumine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Flunixin Meglumine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Flunixin Meglumine Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Flunixin Meglumine Injection market include Wuhan Huisheng Biological Technology Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Zoteis and Virbac Animal Health India Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flunixin Meglumine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flunixin Meglumine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flunixin Meglumine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flunixin Meglumine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Flunixin Meglumine Injection Segment by Company

Wuhan Huisheng Biological Technology Co., Ltd.

Shandong Zhongmu Veterinary Medicine Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Qilu Animal Health Products Co., Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

Hebei New Century Pharmaceutical Co., Ltd.

Baimukang Animal Pharmaceutical Co., Ltd.

Zoteis

Virbac Animal Health India Private Limited

Norbrook

MSD Animal Health

Merck Animal Health

Bengal Remedies Limited

Flunixin Meglumine Injection Segment by Type

10ml/Dose

20ml/ Dose

Flunixin Meglumine Injection Segment by Application

Animal muscle pain

Animal febrile disease

Others

Flunixin Meglumine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Flunixin Meglumine Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Flunixin Meglumine Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Flunixin Meglumine Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Flunixin Meglumine Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flunixin Meglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flunixin Meglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flunixin Meglumine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flunixin Meglumine Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flunixin Meglumine Injection industry.

Chapter 3: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Flunixin Meglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Flunixin Meglumine Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Flunixin Meglumine Injection Industry Trends Table 2. Flunixin Meglumine Injection Industry Drivers Table 3. Flunixin Meglumine Injection Industry Opportunities and Challenges Table 4. Flunixin Meglumine Injection Industry Restraints Table 5. Global Flunixin Meglumine Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Flunixin Meglumine Injection Revenue Share by Company (2021-2026) Table 7. Global Flunixin Meglumine Injection Sales Volume by Company (K Doses) & (2021-2026) Table 8. Global Flunixin Meglumine Injection Sales Volume Share by Company (2021-2026) Table 9. Global Flunixin Meglumine Injection Average Price (US$/Dose) of Company (2021-2026) Table 10. Global Flunixin Meglumine Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Flunixin Meglumine Injection Key Company Manufacturing Base & Headquarters Table 12. Global Flunixin Meglumine Injection Company, Product Type & Application Table 13. Global Flunixin Meglumine Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Flunixin Meglumine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10ml/Dose Table 18. Significant Companies of 20ml/ Dose Table 19. Global Flunixin Meglumine Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Doses) Table 20. Global Flunixin Meglumine Injection Sales Volume by Type (2021-2026) & (K Doses) Table 21. Global Flunixin Meglumine Injection Sales Volume by Type (2027-2032) & (K Doses) Table 22. Global Flunixin Meglumine Injection Sales Volume Share by Type (2021-2026) Table 23. Global Flunixin Meglumine Injection Sales Volume Share by Type (2027-2032) Table 24. Global Flunixin Meglumine Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Flunixin Meglumine Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Flunixin Meglumine Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Flunixin Meglumine Injection Sales Value Share by Type (2021-2026) Table 28. Global Flunixin Meglumine Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Animal muscle pain Table 30. Significant Companies of Animal febrile disease Table 31. Significant Companies of Others Table 32. Global Flunixin Meglumine Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Doses) Table 33. Global Flunixin Meglumine Injection Sales Volume by Application (2021-2026) & (K Doses) Table 34. Global Flunixin Meglumine Injection Sales Volume by Application (2027-2032) & (K Doses) Table 35. Global Flunixin Meglumine Injection Sales Volume Share by Application (2021-2026) Table 36. Global Flunixin Meglumine Injection Sales Volume Share by Application (2027-2032) Table 37. Global Flunixin Meglumine Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Flunixin Meglumine Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Flunixin Meglumine Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Flunixin Meglumine Injection Sales Value Share by Application (2021-2026) Table 41. Global Flunixin Meglumine Injection Sales Value Share by Application (2027-2032) Table 42. Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 43. Global Flunixin Meglumine Injection Sales by Region (2021-2026) & (K Doses) Table 44. Global Flunixin Meglumine Injection Sales Market Share by Region (2021-2026) Table 45. Global Flunixin Meglumine Injection Sales by Region (2027-2032) & (K Doses) Table 46. Global Flunixin Meglumine Injection Sales Market Share by Region (2027-2032) Table 47. Global Flunixin Meglumine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Flunixin Meglumine Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Flunixin Meglumine Injection Sales Value Share by Region (2021-2026) Table 50. Global Flunixin Meglumine Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Flunixin Meglumine Injection Sales Value Share by Region (2027-2032) Table 52. Global Flunixin Meglumine Injection Market Average Price (US$/Dose) by Region (2021-2026) Table 53. Global Flunixin Meglumine Injection Market Average Price (US$/Dose) by Region (2027-2032) Table 54. Global Flunixin Meglumine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Table 55. Global Flunixin Meglumine Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 57. Global Flunixin Meglumine Injection Sales Market Share by Country (2021-2026) Table 58. Global Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 59. Global Flunixin Meglumine Injection Sales Market Share by Country (2027-2032) Table 60. Global Flunixin Meglumine Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Flunixin Meglumine Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Flunixin Meglumine Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Flunixin Meglumine Injection Sales Value Market Share by Country (2027-2032) Table 64. Wuhan Huisheng Biological Technology Co., Ltd. Company Information Table 65. Wuhan Huisheng Biological Technology Co., Ltd. Business Overview Table 66. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 67. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 68. Wuhan Huisheng Biological Technology Co., Ltd. Recent Development Table 69. Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information Table 70. Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview Table 71. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 72. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 73. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development Table 74. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 75. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 76. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 77. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 78. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development Table 79. Qilu Animal Health Products Co., Ltd. Company Information Table 80. Qilu Animal Health Products Co., Ltd. Business Overview Table 81. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 82. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 83. Qilu Animal Health Products Co., Ltd. Recent Development Table 84. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information Table 85. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview Table 86. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 87. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 88. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development Table 89. Hebei New Century Pharmaceutical Co., Ltd. Company Information Table 90. Hebei New Century Pharmaceutical Co., Ltd. Business Overview Table 91. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 92. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 93. Hebei New Century Pharmaceutical Co., Ltd. Recent Development Table 94. Baimukang Animal Pharmaceutical Co., Ltd. Company Information Table 95. Baimukang Animal Pharmaceutical Co., Ltd. Business Overview Table 96. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 97. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 98. Baimukang Animal Pharmaceutical Co., Ltd. Recent Development Table 99. Zoteis Company Information Table 100. Zoteis Business Overview Table 101. Zoteis Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 102. Zoteis Flunixin Meglumine Injection Product Portfolio Table 103. Zoteis Recent Development Table 104. Virbac Animal Health India Private Limited Company Information Table 105. Virbac Animal Health India Private Limited Business Overview Table 106. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 107. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio Table 108. Virbac Animal Health India Private Limited Recent Development Table 109. Norbrook Company Information Table 110. Norbrook Business Overview Table 111. Norbrook Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 112. Norbrook Flunixin Meglumine Injection Product Portfolio Table 113. Norbrook Recent Development Table 114. MSD Animal Health Company Information Table 115. MSD Animal Health Business Overview Table 116. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 117. MSD Animal Health Flunixin Meglumine Injection Product Portfolio Table 118. MSD Animal Health Recent Development Table 119. Merck Animal Health Company Information Table 120. Merck Animal Health Business Overview Table 121. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 122. Merck Animal Health Flunixin Meglumine Injection Product Portfolio Table 123. Merck Animal Health Recent Development Table 124. Bengal Remedies Limited Company Information Table 125. Bengal Remedies Limited Business Overview Table 126. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 127. Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio Table 128. Bengal Remedies Limited Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Flunixin Meglumine Injection Distributors List Table 132. Flunixin Meglumine Injection Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Flunixin Meglumine Injection Product Image Figure 2. Global Flunixin Meglumine Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Flunixin Meglumine Injection Sales (2021-2032) & (K Doses) Figure 5. Global Flunixin Meglumine Injection Sales Average Price (US$/Dose) & (2021-2032) Figure 6. Global Flunixin Meglumine Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10ml/Dose Image Figure 10. 20ml/ Dose Image Figure 11. Global Flunixin Meglumine Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 12. Global Flunixin Meglumine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Flunixin Meglumine Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Flunixin Meglumine Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Flunixin Meglumine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Flunixin Meglumine Injection Sales Value Share by Type (2021-2032) Figure 17. Animal muscle pain Image Figure 18. Animal febrile disease Image Figure 19. Others Image Figure 20. Global Flunixin Meglumine Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 21. Global Flunixin Meglumine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Flunixin Meglumine Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Flunixin Meglumine Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Flunixin Meglumine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Flunixin Meglumine Injection Sales Value Share by Application (2021-2032) Figure 26. Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 27. Global Flunixin Meglumine Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Flunixin Meglumine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Flunixin Meglumine Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Flunixin Meglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Flunixin Meglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Flunixin Meglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Flunixin Meglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Flunixin Meglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Flunixin Meglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Flunixin Meglumine Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Flunixin Meglumine Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml/Dose
  • 20ml/ Dose
Applications
  • Animal muscle pain
  • Animal febrile disease
  • Others
Companies covered
  • Wuhan Huisheng Biological Technology Co., Ltd.
  • Shandong Zhongmu Veterinary Medicine Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Qilu Animal Health Products Co., Ltd.
  • Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  • Hebei New Century Pharmaceutical Co., Ltd.
  • Baimukang Animal Pharmaceutical Co., Ltd.
  • Zoteis
  • Virbac Animal Health India Private Limited
  • Norbrook
  • MSD Animal Health
  • Merck Animal Health
  • Bengal Remedies Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flunixin Meglumine Injection Sales Value (2021-2032)
  4. 1.2.2 Global Flunixin Meglumine Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Flunixin Meglumine Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Flunixin Meglumine Injection Market Dynamics
  1. 2.1 Flunixin Meglumine Injection Industry Trends
  2. 2.2 Flunixin Meglumine Injection Industry Drivers
  3. 2.3 Flunixin Meglumine Injection Industry Opportunities and Challenges
  4. 2.4 Flunixin Meglumine Injection Industry Restraints
3 Flunixin Meglumine Injection Market by Company
  1. 3.1 Global Flunixin Meglumine Injection Company Revenue Ranking in 2025
  2. 3.2 Global Flunixin Meglumine Injection Revenue by Company (2021-2026)
  3. 3.3 Global Flunixin Meglumine Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Flunixin Meglumine Injection Average Price by Company (2021-2026)
  5. 3.5 Global Flunixin Meglumine Injection Company Ranking (2024-2026)
  6. 3.6 Global Flunixin Meglumine Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Flunixin Meglumine Injection Company Product Type and Application
  8. 3.8 Global Flunixin Meglumine Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Flunixin Meglumine Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Flunixin Meglumine Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Flunixin Meglumine Injection Market by Type
  1. 4.1 Flunixin Meglumine Injection Type Introduction
  2. 4.1.1 10ml/Dose
  3. 4.1.2 20ml/ Dose
  4. 4.2 Global Flunixin Meglumine Injection Sales Volume by Type
  5. 4.2.1 Global Flunixin Meglumine Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Flunixin Meglumine Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Flunixin Meglumine Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Flunixin Meglumine Injection Sales Value by Type
  9. 4.3.1 Global Flunixin Meglumine Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Flunixin Meglumine Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Flunixin Meglumine Injection Sales Value Share by Type (2021-2032)
5 Flunixin Meglumine Injection Market by Application
  1. 5.1 Flunixin Meglumine Injection Application Introduction
  2. 5.1.1 Animal muscle pain
  3. 5.1.2 Animal febrile disease
  4. 5.1.3 Others
  5. 5.2 Global Flunixin Meglumine Injection Sales Volume by Application
  6. 5.2.1 Global Flunixin Meglumine Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flunixin Meglumine Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Flunixin Meglumine Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Flunixin Meglumine Injection Sales Value by Application
  10. 5.3.1 Global Flunixin Meglumine Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Flunixin Meglumine Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Flunixin Meglumine Injection Sales Value Share by Application (2021-2032)
6 Flunixin Meglumine Injection Regional Sales and Value Analysis
  1. 6.1 Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flunixin Meglumine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Flunixin Meglumine Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Flunixin Meglumine Injection Sales by Region (2027-2032)
  5. 6.3 Global Flunixin Meglumine Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Flunixin Meglumine Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Flunixin Meglumine Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Flunixin Meglumine Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Flunixin Meglumine Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Flunixin Meglumine Injection Sales Value (2021-2032)
  12. 6.6.2 North America Flunixin Meglumine Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Flunixin Meglumine Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Flunixin Meglumine Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Flunixin Meglumine Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Flunixin Meglumine Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Flunixin Meglumine Injection Sales Value (2021-2032)
  21. 6.9.2 South America Flunixin Meglumine Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Flunixin Meglumine Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Flunixin Meglumine Injection Sales Value Share by Country, 2025 VS 2032
7 Flunixin Meglumine Injection Country-level Sales and Value Analysis
  1. 7.1 Global Flunixin Meglumine Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Flunixin Meglumine Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Flunixin Meglumine Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Flunixin Meglumine Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Flunixin Meglumine Injection Sales by Country (2027-2032)
  6. 7.4 Global Flunixin Meglumine Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Flunixin Meglumine Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Flunixin Meglumine Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Flunixin Meglumine Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Flunixin Meglumine Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Flunixin Meglumine Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Huisheng Biological Technology Co., Ltd.
  2. 8.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
  3. 8.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
  4. 8.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  6. 8.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
  7. 8.2 Shandong Zhongmu Veterinary Medicine Co., Ltd.
  8. 8.2.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
  9. 8.2.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview
  10. 8.2.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  12. 8.2.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
  13. 8.3 Shandong Lukang Pharmaceutical Co., Ltd.
  14. 8.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  18. 8.3.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Qilu Animal Health Products Co., Ltd.
  20. 8.4.1 Qilu Animal Health Products Co., Ltd. Company Information
  21. 8.4.2 Qilu Animal Health Products Co., Ltd. Business Overview
  22. 8.4.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  24. 8.4.5 Qilu Animal Health Products Co., Ltd. Recent Developments
  25. 8.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  26. 8.5.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  30. 8.5.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hebei New Century Pharmaceutical Co., Ltd.
  32. 8.6.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hebei New Century Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  36. 8.6.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Baimukang Animal Pharmaceutical Co., Ltd.
  38. 8.7.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Baimukang Animal Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  42. 8.7.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Zoteis
  44. 8.8.1 Zoteis Company Information
  45. 8.8.2 Zoteis Business Overview
  46. 8.8.3 Zoteis Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zoteis Flunixin Meglumine Injection Product Portfolio
  48. 8.8.5 Zoteis Recent Developments
  49. 8.9 Virbac Animal Health India Private Limited
  50. 8.9.1 Virbac Animal Health India Private Limited Company Information
  51. 8.9.2 Virbac Animal Health India Private Limited Business Overview
  52. 8.9.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
  54. 8.9.5 Virbac Animal Health India Private Limited Recent Developments
  55. 8.10 Norbrook
  56. 8.10.1 Norbrook Company Information
  57. 8.10.2 Norbrook Business Overview
  58. 8.10.3 Norbrook Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Norbrook Flunixin Meglumine Injection Product Portfolio
  60. 8.10.5 Norbrook Recent Developments
  61. 8.11 MSD Animal Health
  62. 8.11.1 MSD Animal Health Company Information
  63. 8.11.2 MSD Animal Health Business Overview
  64. 8.11.3 MSD Animal Health Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
  66. 8.11.5 MSD Animal Health Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
  73. 8.13 Bengal Remedies Limited
  74. 8.13.1 Bengal Remedies Limited Company Information
  75. 8.13.2 Bengal Remedies Limited Business Overview
  76. 8.13.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
  78. 8.13.5 Bengal Remedies Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flunixin Meglumine Injection Value Chain Analysis
  2. 9.1.1 Flunixin Meglumine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flunixin Meglumine Injection Sales Mode & Process
  6. 9.2 Flunixin Meglumine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flunixin Meglumine Injection Distributors
  9. 9.2.3 Flunixin Meglumine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst